FDA approves Celluma (BioPhotas) for treatment of Acne

The FDA has cleared Celluma, a biophotonic medical device, from BioPhotas, for six separate Indications-For-Use, including the treatment of Acne, Muscle and Joint Pain, muscle and joint stiffness, muscle spasm, Arthritis and compromised local blood circulation. Celluma provides light therapy to the body. It uses three distinct wavelengths of light, modulated with proprietary electronic algorithms to effectively treat a variety of skin, muscle and joint conditions. It also has a novel flexible design that molds to the body to allow the light to be absorbed more effectively leading to higher efficacy and more predictable outcomes.